Novel Treatments & Drugs

Mesothelin Could Be Used to Improve Mesothelioma Treatment

Mesothelioma is a hard cancer to treat and understand. Understanding protein expressed by mesothelioma cells could potentially help. This protein may be a clue to the cancer, but an easier way to check for it in a lab needs to be found. In the study, scientists dig into mesothelin, see[…]

Read More »

Radiomics Can Be Used to Improve Mesothelioma Treatment

Malignant mesothelioma is a challenging cancer to treat. New therapies like T cell receptor fusion constructs (TRuCs) show promise. Identifying which patients will benefit from these treatments is important. Radiomics, a field that extracts data from medical images, offers a potential solution. Radiomics may predict treatment responses based on imaging[…]

Read More »

Recurring Collapsed Lung Could Indicate Mesothelioma

A new article highlights the link between a collapsed lung and mesothelioma. Mesothelioma, caused by asbestos exposure, can present unexpectedly due to its long latency period. It often requires many clinical tests for accurate diagnosis and treatment planning. A new study explores the case of a 73-year-old man whose recurrent[…]

Read More »

A Type of T Cell Therapy is Showing Promising Results for Mesothelioma

A clinical trial testing a new type of cell therapy for mesothelioma is actively recruiting patients at sites across the country, including Moffitt Cancer Center in Tampa, Florida. The trial is early stage. The therapy, called Synkir-110, is a lab-engineered cell treatment designed to target mesothelin, a protein found on[…]

Read More »

RSO-021 Controlled Mesothelioma in Two-Thirds of Patients in Study

A new mesothelioma drug controlled the disease in two out of three patients through 12 weeks of treatment. Researchers say it turns cancer’s own defenses against it. Teams at the University of Vermont and University of Leicester led the small, early-phase trial. Their findings were published July 14 in the[…]

Read More »

Mesothelioma Cells are Able to Get Around Different Types of Treatment

Mesothelioma cells have a survival trick. When researchers exposed them to an experimental drug that targeted one of the cancer’s main growth switches, the cells did not die. Instead, they found a way around the drug’s effect. A new study in the journal Nature Structural & Molecular Biology has uncovered[…]

Read More »

Targeting the Collagen Receptor uPARAP to Treat Mesothelioma

Mesothelioma, a cancer with low survival rates, is still a major problem. A major cause of the cancer is asbestos exposure. A new study focuses on a possible treatment target for mesothelioma. The main focus of researchers in the study is the collagen receptor uPARAP. Mesothelioma is mainly caused by[…]

Read More »

Vaccines are Being Studied to Treat Mesothelioma

Vaccines are an important part of preventing infectious diseases from spreading. Vaccines work by utilizing antibody responses and invigorating T-cell immunity. This not only helps with infectious diseases, but it can also help with cancer as well. A new study is looking at a vaccine regimen for mesothelioma. Mesothelioma is[…]

Read More »

Computers Can Be Used to Help Find Treatments for Mesothelioma

There is some exciting news dealing with the fight against mesothelioma. Scientists are using smart computers to figure out better ways to treat patients. This study is a first step towards making treatments that fit each person better. Mesothelioma is a tricky cancer, and finding the right treatments can be[…]

Read More »

Using Mesothelin Nanoprobes to Understand Certain Types of Mesothelioma

Mesothelioma is a tough cancer to have that is hard to diagnose and understand. Scientists are looking at a protein called mesothelin that could possibly help. This protein might be a clue to the cancer, but we need an easier way to find out more about it. In the new[…]

Read More »

Skip to content